Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients
Kerstin Hermelink, Markus Bühner, Philipp Sckopke, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 104

Showing 26-50 of 104 citing articles:

Effects of Cyclophosphamide and/or Doxorubicin in a Murine Model of Postchemotherapy Cognitive Impairment
Timothy J. Flanigan, J Anderson, Ikram Elayan, et al.
Toxicological Sciences (2017) Vol. 162, Iss. 2, pp. 462-474
Open Access | Times Cited: 34
Cognitive Performance and Psychological Distress in Breast Cancer Patients at Disease Onset
Jochen Kaiser, Jörg Dietrich, M Amiri, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 31
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis
Yifei Ma, Nianqi Liu, Yanqi Wang, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101987-101987
Open Access | Times Cited: 10
Comparative effect of Tai Chi and aerobic exercise on cognitive function in advanced lung cancer survivors with perceived cognitive impairment: a three-arm randomized controlled trial with mediation analysis
Naomi Takemura, Denise Shuk Ting Cheung, Dyt Fong, et al.
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 3
A nomogram for predicting the risk of cancer-related cognitive impairment in breast cancer patients based on a scientific symptom model
Zhongtao Zhou, Jiajia Ren, Qiankun Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Psychological resilience and post-traumatic stress disorder as chain mediators between personality traits and cognitive functioning in patients with breast cancer
Xinmiao Zhang, Jingsong Lu, Zhangyi Ding, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Efficacy of Pennebaker’s expressive writing intervention in reducing psychiatric symptoms among patients with first-time cancer diagnosis: a randomized clinical trial
Luana La Marca, Erika Maniscalco, Francesco Fabbiano, et al.
Supportive Care in Cancer (2018) Vol. 27, Iss. 5, pp. 1801-1809
Closed Access | Times Cited: 30
Association of functional dorsal attention network alterations with breast cancer and chemotherapy
Chao‐Yu Shen, Vincent Chin‐Hung Chen, Dah‐Cherng Yeh, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice
Wenjiao Lyu, Mingzi Ouyang, Xiaomeng Ma, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 22
Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 105-129
Closed Access | Times Cited: 15
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
M.L. Gregorowitsch, A. Ghedri, Danny A. Young‐Afat, et al.
Breast Cancer Research and Treatment (2019) Vol. 175, Iss. 2, pp. 429-441
Open Access | Times Cited: 23
Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems
Shannon L. Gutenkunst, Janette Vardy, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 3, pp. 1377-1386
Open Access | Times Cited: 21
Self‐reported cognitive impairment in cervical cancer survivors: A cross‐sectional study
Elisabeth Wang Areklett, Elisabeth Fagereng, Kjersti Bruheim, et al.
Psycho-Oncology (2021) Vol. 31, Iss. 2, pp. 298-305
Open Access | Times Cited: 20
Post‐traumatic stress symptomatology and adjustment of medical oncology practice during the COVID‐19 pandemic among adult patients with cancer in a day care hospital
Florence Joly, Olivier Rigal, Lydia Guittet, et al.
Cancer (2021) Vol. 127, Iss. 24, pp. 4636-4645
Open Access | Times Cited: 18
Effects of Mindfulness-Based Cancer Recovery training on anxiety, depression, post-traumatic stress disorder, and cancer-related fatigue in breast neoplasm patients undergoing chemotherapy
Fan Xu, J. Zhang, Shaoju Xie, et al.
Medicine (2024) Vol. 103, Iss. 23, pp. e38460-e38460
Open Access | Times Cited: 2
Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment
Deborah H. Allen, Jamie Myers, Catherine E. Jansen, et al.
The Journal for Nurse Practitioners (2018) Vol. 14, Iss. 4, pp. 217-224.e5
Open Access | Times Cited: 21
NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer
Oliver Rick, Monika Reuß‐Borst, Timm Dauelsberg, et al.
Psycho-Oncology (2018) Vol. 27, Iss. 8, pp. 2016-2022
Closed Access | Times Cited: 21
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology
Alessandro Allegra, Vanessa Innao, Giorgio Basile, et al.
Expert Review of Hematology (2020) Vol. 13, Iss. 4, pp. 393-404
Closed Access | Times Cited: 18
Preliminary study on the effects of treatment for breast cancer: immunological markers as they relate to quality of life and neuropsychological performance
Michael J. Boivin, Geoffrey Aaron, Nathan G. Felt, et al.
BMC Women s Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review
Miaomiao Jia, Xiaojun Zhang, Liyuan Wei, et al.
Asia-Pacific Journal of Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 321-329
Open Access | Times Cited: 16
Role of stress, age and adjuvant therapy in the cognitive function of patients with breast cancer (Review)
A. Papanastasiou, Theodora Seliniotaki, Emmanouil� Rizos, et al.
Oncology Letters (2019)
Open Access | Times Cited: 17
Association of serum cortisol and cortisone levels and risk of recurrence after endocrine treatment in breast cancer
Feng Wang, Guro F. Giskeødegård, Sissel Skarra, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3883-3893
Open Access | Times Cited: 5
Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy
Zhonglian Huang, Jingjing Zhao, Ke Ding, et al.
Medicine (2019) Vol. 98, Iss. 16, pp. e15301-e15301
Open Access | Times Cited: 12
Detecting microstructural alterations of cerebral white matter associated with breast cancer and chemotherapy revealed by generalized q-sampling MRI
Vincent Chin‐Hung Chen, Wei Chuang, Chien‐Wei Chen, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Higher Stress in Oncology Patients is Associated With Cognitive and Evening Physical Fatigue Severity
Lisa Morse, Steven M. Paul, Bruce A. Cooper, et al.
Journal of Pain and Symptom Management (2022) Vol. 65, Iss. 3, pp. 203-215
Closed Access | Times Cited: 5

Scroll to top